| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| CRUDE OILS | TOX-Non-Repro-Sublethal - whole animal | body weight | no effect | 25/dose | Juvenile | 9 wks | Toxicity Factor Datasets |
| CRUDE OILS | TOX-Non-Repro-Sublethal - cellular/biochemical effects | plasma triglyceride and sodium concentrations, compared to control (based on treatment means at 3, 6, 9 wks) | increase | 25/dose | Juvenile | 9 wks | Toxicity Factor Datasets |
| CRUDE OILS | TOX-Non-Repro-Sublethal - cellular/biochemical effects | hematocrit and plasma cholesterol concentration, compared to control (based on treatment means at 3, 6, 9 wks) | decrease | 25/dose | Juvenile | 9 wks | Toxicity Factor Datasets |
| COREXIT 9527 | TOX-Non-Repro-Sublethal - whole animal | body weight | no effect | 25/dose | Juvenile | 9 wks | Toxicity Factor Datasets |
| COREXIT 9527 | TOX-Non-Repro-Sublethal - cellular/biochemical effects | plasma alanine aminotransferase activity, compared to control | increase | 25/dose | Juvenile | 9 wks | Toxicity Factor Datasets |
